Publications by authors named "Wouter Dercksen"

Claim this Profile
S
Somatostatin analogue continuation upon progression in patients with gastroenteropancreatic neuroendocrine tumour (SAUNA trial): a randomised controlled trial protocol.
Siddharth Chhajlani, Jelka Kuiper, Philippe Beutels, Ivan Borbath, Wouter Dercksen

BMJ Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omission of dexamethasone in paclitaxel premedication regimens: protocol of the multicentre, randomised, non-inferiority DEXASTOP trial.
Michiel Zietse, Luuk C Aalders, Leontine E A M M Spierings, Nikki De Rouw, Wouter Dercksen

BMJ Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case series of metastatic breast cancer patients with visceral crisis treated with CDK4/6 inhibitors.
Marissa Meegdes, Marleen G A M van der Velde, Sandra M E Geurts, Maartje A C E van Kats, M Wouter Dercksen

J Chemother· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry.
Senna W M Lammers, Hannah Thurisch, Ingeborg J H Vriens, Marissa Meegdes, Sanne M E Engelen, M Wouter Dercksen

Breast Cancer Res Treat· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2- metastatic breast cancer: an observational study of the SONABRE Registry.
Marissa Meegdes, Sandra M E Geurts, Frans L G Erdkamp, M Wouter Dercksen, Birgit E P J Vriens

Lancet Reg Health Eur· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Looking bad: Female patients drawing their representation of chemotherapy-induced alopecia.
Anne Versluis, Kirsten van Alphen, Wouter Dercksen, Henk de Haas, Ad A Kaptein

J Health Psychol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Dear hair loss"-illness perceptions of female patients with chemotherapy-induced alopecia.
Anne Versluis, Kirsten van Alphen, Wouter Dercksen, Henk de Haas, Corina van den Hurk

Support Care Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry.
Marissa Meegdes, Khava I E Ibragimova, Dorien J A Lobbezoo, Ingeborg J H Vriens, Loes F S Kooreman, M Wouter Dercksen

Breast Cancer Res Treat· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique Metastatic Patterns in Neuroendocrine Neoplasms of Different Primary Origin.
Bregtje C M Hermans, Judith de Vos-Geelen, Jules L Derks, Loes Latten, Ing Han Liem, M Wouter Dercksen

Neuroendocrinology· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours.
Kris G Samsom, Sonja Levy, Linde M van Veenendaal, Paul Roepman, Liudmila L Kodach, M Wouter Dercksen

Histopathology· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry.
Anouk K M Claessens, Bram L T Ramaekers, Dorien J A Lobbezoo, Roel J W van Kampen, Maaike de Boer, M Wouter Dercksen

Qual Life Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.
Ingeborg J H Vriens, Elena M Ter Welle-Butalid, Maaike de Boer, Christine E M de Die-Smulders, Josien G Derhaag, M Wouter Dercksen

Breast Cancer Res Treat· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2- postmenopausal breast cancer patients treated with everolimus and exemestane.
Dinja T Kruger, Maurice P H M Jansen, Inge R H M Konings, Wouter M Dercksen, Agnes Jager

Mol Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Giving A Face to Chemotherapy-Induced Alopecia: A Feasibility Study on Drawings by Patients.
Kirsten van Alphen, Anne Versluis, Wouter Dercksen, Henk de Haas, Rieneke Lugtenberg

Asia Pac J Oncol Nurs· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraganglion, a pitfall in diagnosis after regular cholecystectomy.
Bartholomeus J G A Corten, Wouter K G Leclercq, M Wouter Dercksen, Wilhelmus T van den Broek, Peter H van Zwam

Int J Surg Case Rep· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).
Stefanie de Groot, Hanno Pijl, Ayoub Charehbili, Saskia van de Ven, Vincent T H B M Smit, M Wouter Dercksen

Breast Cancer Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Infection or metastases? The amoebic abscess].
Thea C Heil, M Wouter Dercksen, S N Blank

Ned Tijdschr Geneeskd· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis.
Maureen J Aarts, Birgit E Vriens, Maaike de Boer, Frank P Peters, Caroline M Mandigers, M Wouter Dercksen

Oncology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium.
Shanly C Seferina, Bram L T Ramaekers, Maaike de Boer, M Wouter Dercksen, Franchette van den Berkmortel

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer: The ROPETAR Randomized Clinical Trial.
Geert A Cirkel, Paul Hamberg, Stefan Sleijfer, Olaf J L Loosveld, M Wouter Dercksen

JAMA Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium.
Shanly C Seferina, Dorien J A Lobbezoo, Maaike de Boer, M Wouter Dercksen, Franchette van den Berkmortel

Oncologist· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonpegylated liposomal doxorubicin: reduction in cardiotoxicity, although still severe alopecia.
Corina van den Hurk, Wim Breed, Wouter Dercksen

Anticancer Drugs· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy.
Antoinetta Beijers, Floortje Mols, Wouter Dercksen, Chantal Driessen, Gerard Vreugdenhil

J Community Support Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia.
Maureen J Aarts, Janneke P Grutters, Frank P Peters, Caroline M Mandigers, M Wouter Dercksen

J Clin Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.
Dorien J A Lobbezoo, Roel J W van Kampen, Adri C Voogd, M Wouter Dercksen, Franchette van den Berkmortel

Breast Cancer Res Treat· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis